Live from the NIH registry
Studies recruiting near Dayton right now
Top 25 of 310 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10119, Centerville, OH — Centerville, Ohio (10.7 mi)
· Sponsor: Colorado Prevention Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Hometown Urgent Care and Research - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Crystalys Therapeutics
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Dayton Physician LLC-Miami Valley Hospital North — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Heart House Research Foundation LLC — Springfield, Ohio (23.0 mi)
· Sponsor: Duke University
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7081 — Dayton, Ohio (1.6 mi)
· Sponsor: Galderma R&D
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Dayton, Ohio (1.6 mi)
· Sponsor: AstraZeneca
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Springfield Medical Center — Springfield, Ohio (23.0 mi)
· Sponsor: Biosense Webster, Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: NRG Oncology
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
Valley Medical Research — Centerville, Ohio (10.7 mi)
· Sponsor: Lantheus Biosciences Ltd.
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Nicole Hamblett
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Premier Blood and Cancer Center — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Dayton Center for Neurological Disorders — Centerville, Ohio (10.7 mi)
· Sponsor: Pfizer
Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness
Pulmonary Embolism Acute
N/A
Interventional 39 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: Angiodynamics, Inc.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Miami Valley Hospital South — Centerville, Ohio (10.7 mi)
· Sponsor: HistoSonics, Inc.
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Cincinnati Children's Hospital Medical Center Liberty — Liberty Township, Ohio (28.1 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Palmoplantar Pustulosis
Phase 3
Interventional 320 participants sought
Ppp001 50202 — Fairborn, Ohio (10.0 mi)
· Sponsor: UCB Biopharma SRL
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro — Springboro, Ohio (15.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Kettering Medical Center — Kettering, Ohio (6.5 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Dayton Center for Neurological Disorders, Merz Investigational Site #0010531 — Centerville, Ohio (10.7 mi)
· Sponsor: Merz Therapeutics GmbH